CARE-PROVIDING AND PRESCRIBING PRACTICES OF PHYSICIANS TREATING CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Author(s)

Patel A1, Medhekar R1, Chen H1, Aparasu RR1, Ochoa-Perez M2, Chan W3, Sherer J1, Alonzo J1
1University of Houston, Houston, TX, USA, 2Legacy Community Health Services, Houston, TX, USA, 3University of Texas Health Science Center, Houston, TX, USA

OBJECTIVES: To compare the care-providing and prescribing practices of physicians treating children and adolescents with attention-deficit/hyperactivity disorder (ADHD). METHODS: A retrospective cohort study was conducted using the GE-EMR data from 1995-2010. The cohort consisted of individuals ≤18 years of age, diagnosed with ADHD (ICD-9 CM: 314.xx) and received a prescription of stimulants or atomoxetine. The NCQA-HEDIS measure for ADHD was used to study the follow-up care. The prescribing physicians were compared on the basis of time-to-treatment, follow-up care, and use of polypharmacy. Multivariate logistic regression was conducted to determine the association of physician specialty with these outcome measures. RESULTS: After applying the inclusion and exclusion criteria the cohort consisted of 66,719 children and adolescents diagnosed and treated for ADHD. 76% (N=50,582) of these cases were identified by PCPs, 2.6% (N=1,724) by child-psychiatrists and the rest by unknown specialty. 59% (N=39,343) of the patients were prescribed ADHD medication on the day of diagnosis and the rest received delayed treatment, with a median time-to-treatment of 57 days (IQR: 22-190). 34% (N=22,476) of the treated cases had follow-up visits in accordance with the HEDIS criteria. Patients identified by PCPs had a mean of 6.56 (SD=3.67) follow-up visits while those identified by child-psychiatrists had a mean of 7.26 (SD=4.10) visits during the 10-month period. Compared to PCPs, child-psychiatrists were 47% less likely to initiate the treatment on same day of diagnosis (OR: 0.53; 95% CI: 0.48-0.59) and identified more comorbid mental disorders (OR: 1.20; 95% CI: 1.02-1.41). Even after controlling for comorbid conditions, child-psychiatrists were 52% more likely to use psychotropic polypharmacy than PCPs (OR: 1.52; 95% CI: 1.35-1.71). CONCLUSIONS: Disparities exist in the care-providing behavior of physicians treating children with ADHD. Additional studies are needed to understand the clinical consequences of these disparities and the implication of care coordination across different provider specialties.

Conference/Value in Health Info

2016-05, ISPOR 2016, Washington DC, USA

Value in Health, Vol. 19, No. 3 (May 2016)

Code

PMH73

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Prescribing Behavior

Disease

Mental Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×